AI English summary of an SEC filing — figures as filed
Quest Diagnostics DGXQuest Diagnostics said on March 9, 2026 its board of directors, after considering the recommendation of the Board's Governance Committee, elected Timothy Wentworth, former chief executive officer of Walgreens Boots Alliance, as a director. Following the election, the board consists of 11 members.
Key points
AI summaryQuest Diagnostics said on March 9, 2026 its board of directors, after considering the recommendation of the Board's Governance Committee, elected Timothy Wentworth, former chief executive officer of Walgreens Boots Alliance, as a director. Following the election, the board consists of 11 members.
The company said the board appointed Mr. Wentworth to serve on the Board's Compensation and Leadership Development Committee and the Board's Quality and Compliance Committee, and determined that he is an independent director pursuant to New York Stock Exchange listing standards and the Company's independence guidelines.
Quest Diagnostics said Mr. Wentworth receives compensation as a non-employee director in accordance with the Company's non-employee director compensation practices, and received a prorated one-time grant of 1 restricted share units valued at approximately $43,000 upon becoming a member of the Company's Board.
The company said in its press release that Mr. Wentworth, as chief executive officer of Walgreens Boots Alliance, helped restructure the company for its sale to Sycamore Partners in mid-2025, and prior to that served as founding CEO of Evernorth Health Services and as president and CEO of Express Scripts.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Timothy Wentworth Elected to Board of Directors
Quest Diagnostics said on March 9, 2026 its board of directors, after considering the recommendation of the Board's Governance Committee, elected Timothy Wentworth, former chief executive officer of Walgreens Boots Alliance, as a director. Following the election, the board consists of 11 members.
Source · Based on the filing body and exhibits
Committee Appointments and Independent Director Determination
The company said the board appointed Mr. Wentworth to serve on the Board's Compensation and Leadership Development Committee and the Board's Quality and Compliance Committee, and determined that he is an independent director pursuant to New York Stock Exchange listing standards and the Company's independence guidelines.
Source · Based on the filing body and exhibits
Non-Employee Director Compensation
Quest Diagnostics said Mr. Wentworth receives compensation as a non-employee director in accordance with the Company's non-employee director compensation practices, and received a prorated one-time grant of 1 restricted share units valued at approximately $43,000 upon becoming a member of the Company's Board.
Source · Based on the filing body and exhibits
Wentworth's Background
The company said in its press release that Mr. Wentworth, as chief executive officer of Walgreens Boots Alliance, helped restructure the company for its sale to Sycamore Partners in mid-2025, and prior to that served as founding CEO of Evernorth Health Services and as president and CEO of Express Scripts.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…